2015-2025 Global Opioid Induced Constipation Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

July 2020 | 139 pages | ID: 26FBB4588FE0EN
99Strategy

Abstracts

SUMMARY

The global Opioid Induced Constipation Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Ironwood Pharmaceuticals Inc
• Daiichi Sankyo Co Ltd
• Pfizer
• Progenics Pharmaceuticals Inc
• Shionogi & Co., Ltd
• Allergan Plc
• Nektar Therapeutics
• Purdue Pharma
• S.L.A. Pharma AG
• Mundipharma International Limited
• Ono Pharmaceutical Co., Ltd
• Takeda Pharmaceutical Company Limited
• Theravance Biopharma Inc
• Valeant Pharmaceuticals International
• Cosmo Pharmaceuticals SA
• Daewoong Pharmaceutical
• C.B. Fleet Company
• Sucampo Pharmaceuticals

Key Types

• Lubiprostone
• Methyl Naltrexone Bromide
• Naldemedine
• Alvimopan
• Others

Key End-Use

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Table America Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Opioid Induced Constipation Drugs Production Forecast
Figure Global Opioid Induced Constipation Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Opioid Induced Constipation Drugs Forecast by Type
Table Global Opioid Induced Constipation Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Opioid Induced Constipation Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Opioid Induced Constipation Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Opioid Induced Constipation Drugs Forecast by End-Use (2020E-2025F)
Table Global Opioid Induced Constipation Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Opioid Induced Constipation Drugs Forecast by Region (2020E-2025F)
Table Global Opioid Induced Constipation Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Opioid Induced Constipation Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Ironwood Pharmaceuticals Inc
  9.1.1 Ironwood Pharmaceuticals Inc Profile
Table Ironwood Pharmaceuticals Inc Overview List
  9.1.2 Ironwood Pharmaceuticals Inc Products & Services
  9.1.3 Ironwood Pharmaceuticals Inc Company Dynamics & News
  9.1.4 Ironwood Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Ironwood Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Daiichi Sankyo Co Ltd
  9.2.1 Daiichi Sankyo Co Ltd Profile
Table Daiichi Sankyo Co Ltd Overview List
  9.2.2 Daiichi Sankyo Co Ltd Products & Services
  9.2.3 Daiichi Sankyo Co Ltd Company Dynamics & News
  9.2.4 Daiichi Sankyo Co Ltd Business Operation Conditions
Table Business Operation of Daiichi Sankyo Co Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Pfizer
  9.3.1 Pfizer Profile
Table Pfizer Overview List
  9.3.2 Pfizer Products & Services
  9.3.3 Pfizer Company Dynamics & News
  9.3.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Progenics Pharmaceuticals Inc
  9.4.1 Progenics Pharmaceuticals Inc Profile
Table Progenics Pharmaceuticals Inc Overview List
  9.4.2 Progenics Pharmaceuticals Inc Products & Services
  9.4.3 Progenics Pharmaceuticals Inc Company Dynamics & News
  9.4.4 Progenics Pharmaceuticals Inc Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Shionogi & Co., Ltd
  9.5.1 Shionogi & Co., Ltd Profile
Table Shionogi & Co., Ltd Overview List
  9.5.2 Shionogi & Co., Ltd Products & Services
  9.5.3 Shionogi & Co., Ltd Company Dynamics & News
  9.5.4 Shionogi & Co., Ltd Business Operation Conditions
Table Business Operation of Shionogi & Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Allergan Plc
  9.6.1 Allergan Plc Profile
Table Allergan Plc Overview List
  9.6.2 Allergan Plc Products & Services
  9.6.3 Allergan Plc Company Dynamics & News
  9.6.4 Allergan Plc Business Operation Conditions
Table Business Operation of Allergan Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Nektar Therapeutics
  9.7.1 Nektar Therapeutics Profile
Table Nektar Therapeutics Overview List
  9.7.2 Nektar Therapeutics Products & Services
  9.7.3 Nektar Therapeutics Company Dynamics & News
  9.7.4 Nektar Therapeutics Business Operation Conditions
Table Business Operation of Nektar Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Purdue Pharma
  9.8.1 Purdue Pharma Profile
Table Purdue Pharma Overview List
  9.8.2 Purdue Pharma Products & Services
  9.8.3 Purdue Pharma Company Dynamics & News
  9.8.4 Purdue Pharma Business Operation Conditions
Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 S.L.A. Pharma AG
  9.9.1 S.L.A. Pharma AG Profile
Table S.L.A. Pharma AG Overview List
  9.9.2 S.L.A. Pharma AG Products & Services
  9.9.3 S.L.A. Pharma AG Company Dynamics & News
  9.9.4 S.L.A. Pharma AG Business Operation Conditions
Table Business Operation of S.L.A. Pharma AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Mundipharma International Limited
  9.10.1 Mundipharma International Limited Profile
Table Mundipharma International Limited Overview List
  9.10.2 Mundipharma International Limited Products & Services
  9.10.3 Mundipharma International Limited Company Dynamics & News
  9.10.4 Mundipharma International Limited Business Operation Conditions
Table Business Operation of Mundipharma International Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Ono Pharmaceutical Co., Ltd
  9.11.1 Ono Pharmaceutical Co., Ltd Profile
Table Ono Pharmaceutical Co., Ltd Overview List
  9.11.2 Ono Pharmaceutical Co., Ltd Products & Services
  9.11.3 Ono Pharmaceutical Co., Ltd Company Dynamics & News
  9.11.4 Ono Pharmaceutical Co., Ltd Business Operation Conditions
Table Business Operation of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Takeda Pharmaceutical Company Limited
  9.12.1 Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Overview List
  9.12.2 Takeda Pharmaceutical Company Limited Products & Services
  9.12.3 Takeda Pharmaceutical Company Limited Company Dynamics & News
  9.12.4 Takeda Pharmaceutical Company Limited Business Operation Conditions
Table Business Operation of Takeda Pharmaceutical Company Limited (Sales Revenue, Cost, Gross Margin)
9.13 Theravance Biopharma Inc
  9.13.1 Theravance Biopharma Inc Profile
Table Theravance Biopharma Inc Overview List
  9.13.2 Theravance Biopharma Inc Products & Services
  9.13.3 Theravance Biopharma Inc Company Dynamics & News
  9.13.4 Theravance Biopharma Inc Business Operation Conditions
Table Business Operation of Theravance Biopharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Valeant Pharmaceuticals International
  9.14.1 Valeant Pharmaceuticals International Profile
Table Valeant Pharmaceuticals International Overview List
  9.14.2 Valeant Pharmaceuticals International Products & Services
  9.14.3 Valeant Pharmaceuticals International Company Dynamics & News
  9.14.4 Valeant Pharmaceuticals International Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals International (Sales Revenue, Cost, Gross Margin)
9.15 Cosmo Pharmaceuticals SA
  9.15.1 Cosmo Pharmaceuticals SA Profile
Table Cosmo Pharmaceuticals SA Overview List
  9.15.2 Cosmo Pharmaceuticals SA Products & Services
  9.15.3 Cosmo Pharmaceuticals SA Company Dynamics & News
  9.15.4 Cosmo Pharmaceuticals SA Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals SA (Sales Revenue, Cost, Gross Margin)
9.16 Daewoong Pharmaceutical
  9.16.1 Daewoong Pharmaceutical Profile
Table Daewoong Pharmaceutical Overview List
  9.16.2 Daewoong Pharmaceutical Products & Services
  9.16.3 Daewoong Pharmaceutical Company Dynamics & News
  9.16.4 Daewoong Pharmaceutical Business Operation Conditions
Table Business Operation of Daewoong Pharmaceutical (Sales Revenue, Cost, Gross Margin)
9.17 C.B. Fleet Company
  9.17.1 C.B. Fleet Company Profile
Table C.B. Fleet Company Overview List
  9.17.2 C.B. Fleet Company Products & Services
  9.17.3 C.B. Fleet Company Company Dynamics & News
  9.17.4 C.B. Fleet Company Business Operation Conditions
Table Business Operation of C.B. Fleet Company (Sales Revenue, Cost, Gross Margin)
9.18 Sucampo Pharmaceuticals
  9.18.1 Sucampo Pharmaceuticals Profile
Table Sucampo Pharmaceuticals Overview List
  9.18.2 Sucampo Pharmaceuticals Products & Services
  9.18.3 Sucampo Pharmaceuticals Company Dynamics & News
  9.18.4 Sucampo Pharmaceuticals Business Operation Conditions
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Opioid Induced Constipation Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid Induced Constipation Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid Induced Constipation Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid Induced Constipation Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Opioid Induced Constipation Drugs Market Concentration Ratio in 2020E
Figure America Opioid Induced Constipation Drugs Market Concentration Ratio in 2020E
Figure Asia Opioid Induced Constipation Drugs Market Concentration Ratio in 2020E
Figure Oceania Opioid Induced Constipation Drugs Market Concentration Ratio in 2020E
Figure Africa Opioid Induced Constipation Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON OPIOID INDUCED CONSTIPATION DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 OPIOID INDUCED CONSTIPATION DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Opioid Induced Constipation Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Opioid Induced Constipation Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Opioid Induced Constipation Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Opioid Induced Constipation Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Opioid Induced Constipation Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioid Induced Constipation Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Opioid Induced Constipation Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Opioid Induced Constipation Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Opioid Induced Constipation Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Opioid Induced Constipation Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Opioid Induced Constipation Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Ironwood Pharmaceuticals Inc  Overview List
Table Business Operation of Ironwood Pharmaceuticals Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Co Ltd  Overview List
Table Business Operation of Daiichi Sankyo Co Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer  Overview List
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals Inc  Overview List
Table Business Operation of Progenics Pharmaceuticals Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shionogi & Co., Ltd  Overview List
Table Business Operation of Shionogi & Co., Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Allergan Plc  Overview List
Table Business Operation of Allergan Plc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nektar Therapeutics  Overview List
Table Business Operation of Nektar Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Purdue Pharma  Overview List
Table Business Operation of Purdue Pharma  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table S.L.A. Pharma AG  Overview List
Table Business Operation of S.L.A. Pharma AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mundipharma International Limited  Overview List
Table Business Operation of Mundipharma International Limited  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ono Pharmaceutical Co., Ltd  Overview List
Table Business Operation of Ono Pharmaceutical Co., Ltd  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Pharmaceutical Company Limited  Overview List
Table Business Operation of Takeda Pharmaceutical Company Limited  (Sales Revenue, Cost, Gross Margin)
Table Theravance Biopharma Inc  Overview List
Table Business Operation of Theravance Biopharma Inc  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals International  Overview List
Table Business Operation of Valeant Pharmaceuticals International  (Sales Revenue, Cost, Gross Margin)
Table Cosmo Pharmaceuticals SA  Overview List
Table Business Operation of Cosmo Pharmaceuticals SA  (Sales Revenue, Cost, Gross Margin)
Table Daewoong Pharmaceutical  Overview List
Table Business Operation of Daewoong Pharmaceutical  (Sales Revenue, Cost, Gross Margin)
Table C.B. Fleet Company  Overview List
Table Business Operation of C.B. Fleet Company  (Sales Revenue, Cost, Gross Margin)
Table Sucampo Pharmaceuticals Overview List
Table Business Operation of Sucampo Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Opioid Induced Constipation Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioid Induced Constipation Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioid Induced Constipation Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioid Induced Constipation Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Opioid Induced Constipation Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioid Induced Constipation Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Opioid Induced Constipation Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Opioid Induced Constipation Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Opioid Induced Constipation Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Opioid Induced Constipation Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioid Induced Constipation Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Opioid Induced Constipation Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Opioid Induced Constipation Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Opioid Induced Constipation Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Opioid Induced Constipation Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Opioid Induced Constipation Drugs Consumption Volume Share by Region in 2025 (Volume)